News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ZASLOFF MICHAEL A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 12,759 shares
@ $57.2165, valued at
$730k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 2,716 shares
@ $0
Granted 7,016 options to buy
@ $46.01, valued at
$322.8k
|
|
| 05/16/2023 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 7,500 shares
@ $42.178, valued at
$316.3k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $33.7069, valued at
$337.1k
Exercised 10,000 options to buy
@ $17.11, valued at
$171.1k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 5,851 shares
@ $0
Granted 16,004 options to buy
@ $20.08, valued at
$321.4k
|
|
| 05/18/2020 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 14,832 shares
@ $18, valued at
$267k
Sold 22,950 shares
@ $18.0253, valued at
$413.7k
Exercised 14,832 options to buy
@ $15.11, valued at
$224.1k
Exercised 22,950 options to buy
@ $15.11, valued at
$346.8k
|
|
| 05/14/2020 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $19, valued at
$190k
Exercised 10,000 options to buy
@ $15.11, valued at
$151.1k
|
|
| 06/13/2019 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 5,491 shares
@ $0
Granted 13,915 options to buy
@ $20.03, valued at
$278.7k
|
|
| 11/15/2018 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 29,278 shares
@ $20.389, valued at
$596.9k
Exercised 29,278 options to buy
@ $14.66, valued at
$429.2k
|
|
| 06/13/2018 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 15,000 shares
@ $16.5228, valued at
$247.8k
|
|
| 06/11/2018 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 6,590 shares
@ $0
Granted 16,679 options to buy
@ $16.69, valued at
$278.4k
|
|
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2017 |
4
| ZASLOFF MICHAEL A (Director) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 15,000 shares
@ $17.0134, valued at
$255.2k
Exercised 15,000 options to buy
@ $10.77, valued at
$161.6k
|
|
| 08/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|